Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

50.38 -1.73 (-3.32%)
Streaming Delayed Price Updated: 2:50 PM EST, Dec 6, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 427,664
Open 52.12
Bid (Size) 50.37 (1)
Ask (Size) 50.41 (1)
Prev. Close 52.11
Today's Range 50.30 - 52.18
52wk Range 42.51 - 86.95
Shares Outstanding 78,294,139
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
The company has already made plenty of investors happy. 
Via The Motley Fool
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
These top players are ripe for recovery -- and long-term growth. 
Via The Motley Fool

Performance

YTD
-38.34%
-38.34%
1 Month
+1.37%
+1.37%
3 Month
-19.73%
-19.73%
6 Month
-21.55%
-21.55%
1 Year
-29.16%
-29.16%

More News

Read More
3 Growth Stocks That Are Too Cheap to Ignore
Via The Motley Fool
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
2 Stocks Near 52-Week Highs That Could Climb Higher
Via The Motley Fool
What 5 Analyst Ratings Have To Say About CRISPR Therapeutics
Via Benzinga
Why Shares of CRISPR Therapeutics Dropped 19.9% in October
Via The Motley Fool
Where CRISPR Therapeutics Stands With Analysts
Via Benzinga
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Via The Motley Fool
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Via Benzinga
Where Will Editas Medicine Be in 1 Year?
Via The Motley Fool
2 Growth Stocks That Could Double in 2023
Via The Motley Fool
Crispr Therapeutics Stock: Bull vs. Bear
Via The Motley Fool
5 Top Stocks to Buy Before 2023
Via The Motley Fool
Vertex Pharmaceuticals: Buy at the High?
Via The Motley Fool
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
Via The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Via Benzinga
3 Healthcare Stocks That Could Go Parabolic
Via The Motley Fool
Got $1,000? 2 Smart Stocks to Consider Buying Right Now
Via The Motley Fool
2 Biotech Stocks That Could Make You Richer
Via The Motley Fool
3 Top Healthcare Stocks to Buy for November
Via The Motley Fool
What 8 Analyst Ratings Have To Say About CRISPR Therapeutics
Via Benzinga
Expert Ratings for CRISPR Therapeutics
Via Benzinga
Better Buy: CRISPR Therapeutics vs. Bluebird Bio
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.